Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-09

Clinical Trial Update: Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

View source ↗

Summary

A completed clinical trial assessing the efficacy of telbivudine in chronic hepatitis B patients, reporting endpoints such as 24-week PCR negativity, longer-ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telbivudine (Tyzeka) (telbivudine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis B, Roadmap Concept in Chronic Hepatitis B Treatment | Status: COMPLETED